Deming Zhang
Overview
Explore the profile of Deming Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang D, Wang W, Song C, Huang T, Chen H, Liu Z, et al.
iScience
. 2024 Dec;
27(12):111330.
PMID: 39650731
Non-typeable (NTHi) is a common pathogen causing respiratory infections, including pneumonia in children, and can also be found in the upper respiratory tracts of asymptomatic individuals. This study examines genomic...
2.
Huang H, Zhang J, Wu J, Du C, Zheng B, Guo Z, et al.
Anticancer Drugs
. 2024 Mar;
35(6):535-541.
PMID: 38527238
Glioblastoma (GBM) is the most common primary malignant brain tumour and lacks therapeutic options with significant effects. The aberrant activation of STAT3 is a critical factor in glioma progression via...
3.
Gao S, Xie X, Fan L, Zhang D
Exp Ther Med
. 2023 Oct;
26(5):515.
PMID: 37840562
Vortioxetine is a novel drug for the treatment of major depressive disorder (MDD). It has been reported that vortioxetine exhibits positive effect on the acute stage of MDD, while it...
4.
Guo Y, Bruno G, Zhang D, Han K
Heliyon
. 2023 Sep;
9(10):e20308.
PMID: 37767483
Background And Aim: Low-carbon technology innovation(L-CTI) is an essential way to realize the socio-economic transition to a low-carbon model. However, relatively few studies have been conducted on the calculation of...
5.
Huang D, Wang X, Qian Y, Wu J, Chen B, Zhang D, et al.
Cell Immunol
. 2023 Mar;
386:104706.
PMID: 36931054
Immune checkpoint blockade (ICB) therapies, such as monoclonal antibodies against the PD-1/PD-L1 immune checkpoint pathway, have been a major breakthrough in the treatment of lung cancer especially lung adenocarcinoma (LUAD),...
6.
Zhang D, Pan G, Cheng N, Sun L, Zhou X, Li C, et al.
Tissue Cell
. 2023 Jan;
81:102010.
PMID: 36608637
Objective: Esophageal squamous cell carcinoma (ESCC) is a globally aggressive malignant tumor. This study aimed to investigate the mechanism of JUND in ESCC development via MAPRE2. Methods: ESCC cells (KYSE-450...
7.
Zheng H, Cao H, Zhang D, Huang J, Li J, Wang S, et al.
Front Microbiol
. 2022 Apr;
13:810230.
PMID: 35369439
This study investigated the effects of (CM) on intestinal barrier function and gut microbiota in a pig model. A total of 160 pigs were randomly allocated to either a control...
8.
Zhang D, Li C, Cheng N, Sun L, Zhou X, Pan G, et al.
Acta Histochem
. 2021 Aug;
123(7):151776.
PMID: 34461454
Objective: This work aims to determine the role of circular RNA (circRNA) AGFG1 and related molecular mechanism in esophageal squamous cell carcinoma (ESCC) cells. Methods: CircAGFG1 expression in ESCC cell...
9.
Li Y, Hu Y, Wu Y, Zhang D, Huang D
Lab Med
. 2021 Jul;
53(1):39-46.
PMID: 34270733
The emerging role of long noncoding RNAs (lncRNAs) in cancer, especially in lung adenocarcinoma (LUAD), is attracting increasingly more attention as a potential therapeutic target. However, whether lncRNA LINC00205 regulates...
10.
Zhou L, Wang Z, Wang Z, Zhu J, Feng Y, Zhang D, et al.
J Biomed Mater Res A
. 2021 Apr;
109(10):1979-1989.
PMID: 33822474
Native decellularized extracellular matrix provides an adequate platform for tissues and organs and promotes the development of organogenesis and tissue remodeling. However, thrombosis poses a great challenge that hinders the...